pharma · Mild/non-serious osteoarthritis (OA) of the knee.
Haleon - Gebro
HALEON AUSTRALIA PTY LTD
Haleon - Gebro clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Fieberbrunn, AU
- Employees
- 179
- Programs
- 3
- Drugs
- 9
- Patents
- 0
Haleon - Gebro projects
3 ClinicalTrials.gov programs sponsored by Haleon - Gebro.
Haleon - Gebro has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
300141
HALEON AUSTRALIA PTY LTD
Healthy volunteers, therapeutic indication not studied
1 trial -
400314
HALEON AUSTRALIA PTY LTD
For the local, symptomatic treatment of pain in acute bruises, strains, or sprains due to blunt trauma, e.g., sports and accident injuries
1 trial -
300128
HALEON AUSTRALIA PTY LTD
Mild/non-serious osteoarthritis (OA) of the knee.
1 trial
Frequently asked questions
How many clinical projects does Haleon - Gebro have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.